Deutsche Bank Aktiengesellschaft Boosts Genus (LON:GNS) Price Target to GBX 3,100

Genus (LON:GNS) had its price target hoisted by research analysts at Deutsche Bank Aktiengesellschaft from GBX 2,900 to GBX 3,100 in a research report issued on Wednesday,London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 22.64% from the company’s previous close.

Separately, Shore Capital boosted their target price on shares of Genus from GBX 2,900 to GBX 3,000 and gave the stock a “buy” rating in a research report on Wednesday. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of GBX 3,050.

Genus Stock Down 2.2%

LON:GNS traded down GBX 57.36 on Wednesday, hitting GBX 2,527.64. The stock had a trading volume of 8,100,646 shares, compared to its average volume of 285,518. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. Genus has a 52 week low of GBX 1,424 and a 52 week high of GBX 3,228.80. The business’s fifty day moving average is GBX 2,497.98 and its 200 day moving average is GBX 2,351.15. The company has a market cap of £1.67 billion, a PE ratio of 87.46, a P/E/G ratio of 2.87 and a beta of 0.37.

Genus (LON:GNS) last issued its earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, equities research analysts expect that Genus will post 70.9644323 EPS for the current fiscal year.

Insiders Place Their Bets

In other Genus news, insider Jorgen Kokke sold 3,450 shares of the company’s stock in a transaction on Thursday, September 25th. The stock was sold at an average price of GBX 2,332, for a total value of £80,454. Corporate insiders own 0.70% of the company’s stock.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.